通过UPLC-PDA对Etoricoxib在低血体积的量化,并应用于临床前药理动力学研究
Sapir Ifrah1, Daniel Porat1, Mordechai Deutsch2
1Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
一种新的超高性能液态色谱法准确地量化了老鼠血中的埃托里可西布. 这种快速而敏感的测定方法非常适合在临床前和临床研究中对药物进行监测.
科学领域:
- 分析化学 分析化学
- 药理动力学 药理动力学
背景情况:
- 埃托里科西布是一种选择性循环氧化酶-2 (COX-2) 抑制剂.
- 在生物矩阵中精确量化埃托里可西布对于药理动力学研究至关重要.
- 现有的方法可能缺乏简单性,速度或对低血体积的敏感性.
研究的目的:
- 开发和验证一种简单,快速,选择性和灵敏的超高性能液态色谱与光二极管阵列 (UPLC-PDA) 紫外线检测方法.
- 在小的血体积 (50微升) 中量化埃托里科克西布.
- 在大鼠的药理动力学研究中应用该方法.
主要方法:
- 该方法涉及蛋白质沉和液液提取.
- 使用了水的梯度移动相:酸,流量为1毫升/分钟.
- 使用光二极管阵列 (UPLC-PDA) 紫外线检测的超高性能液态色谱.
主要成果:
- 该方法在广泛的度范围 (0.1-12μg/mL) 上显示出出色的线性 (r2 = 1).
- 实现了短运行时间 (8分钟),短保留时间,高稳定性,恢复,准确性,精度和可重复性.
- 获得了低检测极限 (LOD: 20 ng/mL) 和定量 (LOQ: 100 ng/mL) 的埃托里可西布.
结论:
- 开发的UPLC-PDA方法对于在低血体积中量化埃托里科西布是有效的.
- 该方法具有时间和成本效益,适用于临床前和临床环境中的药物监测.
- 在大鼠的药理动力学研究中成功应用验证了它的实用性.
更多相关视频
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
08:38Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
相关概念视频
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
Drug Concentration Versus Time Correlation
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
On...
Volume of Distribution
